This article provides general legal information, not legal advice. Laws vary by state and by the facts of each case. Reading this page does not create an attorney-client relationship. For advice about your situation, consult a licensed attorney in your state.

Looking into a paraquat lawsuit can feel overwhelming, especially after a Parkinson's disease diagnosis has already upended everyday life. Many families are juggling treatment, work changes, and uncertainty at the same time. Then they run into headlines about bellwether trials, MDL updates, and possible settlements that do not always line up.

As of April 2026, the federal paraquat litigation remains active in MDL No. 3004 , with thousands of pending actions in the Southern District of Illinois. The science picture is still contested. Some epidemiology studies report associations between paraquat exposure and Parkinson's disease, while regulators such as EPA say they have not found a clear causal link from labeled uses.

This guide breaks the issue down in plain English: what the paraquat lawsuit is about, who may qualify, what compensation may be available, how filing deadlines can work, and where the litigation stands now. It also explains why timing matters and why results can change from one state to another. If you are worried about a deadline, talk with a licensed attorney in your state promptly.

What Is the Paraquat Lawsuit?

The paraquat lawsuit is a product-liability mass tort centered on whether exposure to paraquat-containing herbicides contributed to Parkinson's disease and whether manufacturers failed to give adequate warnings. The main federal proceeding is In re: Paraquat Products Liability Litigation, MDL 3004 , pending in the U.S. District Court for the Southern District of Illinois.

This is not a class action where one ruling automatically resolves every claim. An MDL (multidistrict litigation, a procedure that centralizes pretrial proceedings) coordinates discovery and motion practice for efficiency, but each claimant still generally needs proof of exposure, diagnosis, causation, and a timely filing.

Court materials and case-management orders identify major defendants including Syngenta entities and Chevron U.S.A. Inc., with historical allegations involving paraquat products such as Gramoxone and certain generic formulations. The court's April 17, 2024 Daubert order also discusses historical manufacturing roles and expert-evidence disputes. Read the official order.

Who May Qualify for a Paraquat Lawsuit?

No public checklist can guarantee eligibility. In general, stronger paraquat lawsuit claims tend to involve three things: documented paraquat exposure, a confirmed Parkinson's disease diagnosis, and filing within the applicable statute of limitations (the deadline to file a lawsuit).

Claims are often built around licensed applicators, mixers, loaders, handlers, and agricultural workers with repeated occupational exposure. Some proximity-exposure claims may also exist, but they are usually more fact-intensive because they require stronger proof about location, timing, and likely route of exposure.

Records that often help include:

  • Neurology records showing the Parkinson's disease diagnosis date and progression.
  • Work records showing pesticide application, mixing, loading, or repeated handling.
  • Product history tied to paraquat brands or formulations used over time.
  • Address or field-location history that supports proximity arguments near treated areas.
  • Corroborating documents such as training logs, purchase records, or witness statements.

Claims can be harder to pursue when exposure was isolated, Parkinson's disease has not been diagnosed, or the facts cannot be tied to paraquat with reasonable specificity. Because proof and filing rules vary by state, a case-specific legal review matters.

If you want a practical first step before chasing down every record, start with Do I Qualify? and organize your timeline for attorney review.

What Compensation May Be Available in a Paraquat Lawsuit?

Compensation is case-specific and never guaranteed. Depending on the facts, a claimant may seek medical costs, lost income, reduced earning capacity, and pain and suffering. Some cases also involve wrongful-death damages. In some states, punitive damages may also be available under narrow standards.

Potential value can vary based on diagnosis severity, age, disease progression, exposure duration, documentation quality, and venue-specific law. It can also be affected by case-management rulings and expert-admissibility outcomes in the MDL, including Rule 702/Daubert decisions. Read the official April 2024 Daubert ruling.

Settlement discussions have been referenced in federal orders, but there is no public basis for promising any specific payout in an individual case. The December 30, 2025 order extending the stay notes that the extension was intended to allow settlement process discussions to continue.

What Is the Filing Deadline for a Paraquat Lawsuit?

Filing deadlines are one of the most important parts of any paraquat lawsuit review. Many states often cited in paraquat cases use a two-year baseline for personal-injury actions. But latent-disease disputes can change when that clock actually starts.

Examples of baseline injury statutes often cited in current paraquat coverage include:

These statutes are starting points, not complete deadline calculators. Discovery rules, wrongful-death rules, tolling issues, and conflict-of-law questions can all change the real deadline. Laws vary by state, so timing should be reviewed with counsel using the full medical and exposure timeline.

What Is the Current Status of MDL 3004 in 2026?

The paraquat MDL remains active, but the procedural posture is fluid. The JPML April 1, 2026 pending-docket report shows 6,542 pending actions and 8,329 total historical actions transferred, placing paraquat among the larger active product-liability MDLs.

The court record shows a moving schedule for trial planning and settlement talks. The court's January 23, 2025 order selected six cases for case-specific discovery and set phase-based trial targets. Later, the court extended a stay of case-specific deadlines through March 6, 2026 so settlement discussions could continue. Read the official stay order.

By February 2026, the court also referred to a pending defense partial-summary-judgment motion on failure-to-warn claims and changed the voluntary-dismissal process in CMO 23 . The practical takeaway is straightforward: the litigation is active, but the path is not linear.

What Does the Science Say About Paraquat and Parkinson's Disease?

Scientific evidence sits at the center of these cases, and it needs careful framing. Some human studies report associations between paraquat exposure and higher Parkinson's risk in certain settings. For example, a well-known California Central Valley study reported higher risk estimates tied to paraquat and maneb exposure near agricultural applications. Read the study.

Other public materials describe a more mixed record. California DPR's December 2024 preliminary human-health report discussed newer paraquat-specific analyses. It noted moderate to strong associations in some proxy exposure models, but it also said those findings weakened when paraquat was isolated from multi-pesticide patterns. Read the DPR report.

Regulators, however, have not framed causation the same way. EPA's paraquat page states that after reviewing available data it has not found a clear link between paraquat exposure from labeled uses and outcomes such as Parkinson's disease. Read the EPA page.

Likewise, DPR's December 2024 public findings say the evidence reviewed did not demonstrate a direct causal association, even while acknowledging studies that reported positive associations. Read the DPR announcement.

In court, that tension usually turns into a fight over expert evidence. The MDL has already seen major Rule 702 and Daubert rulings. The most accurate summary for readers is not certainty. It is a contested scientific record in which some studies support an association and regulators still dispute clear causation.

Is Paraquat Still Legal in the United States in 2026?

Paraquat remains federally registered in 2026, but with strict restrictions. EPA classifies it as a Restricted Use Pesticide, meaning it is limited to trained certified applicators. EPA also states there are no homeowner uses. Read the EPA restrictions summary.

EPA also says registration review remains open and references additional vapor-pressure data and a data call-in process. California is running a parallel reevaluation through DPR. Read the DPR reevaluation notice.

How to File a Paraquat Claim: Step-by-Step

People often ask whether they should wait for a global resolution before taking action. In many cases, waiting increases risk because statutes of limitations keep running regardless of media coverage. The MDL may shape scheduling and discovery, but it does not automatically pause every claimant's deadline. Early case evaluation is usually about preserving options, not forcing a final decision right away.

It is also common to see confusion between direct-exposure and proximity-exposure narratives. Direct-use cases usually come with clearer records showing repeated handling, mixing, or spraying. Proximity cases may still be viable in some fact patterns, but they often require stronger geospatial and timeline evidence to support the alleged exposure path.

  1. Confirm diagnosis details. Obtain complete neurology records, the diagnosis date, and treatment history.
  2. Build your exposure timeline. List jobs, tasks, products used, years, locations, and anyone who can verify the work history.
  3. Preserve supporting evidence. Keep training certificates, pesticide records, purchase receipts, and relevant field or employment documents.
  4. Evaluate deadline risk early. Do not assume the clock starts at exposure. In latent-disease cases, accrual may be disputed and state-specific.
  5. Get state-specific legal review. Because filing rules vary, consult a licensed attorney in your state before relying on generalized online timelines.
  6. Track MDL and settlement developments. Case-management orders can change process expectations, including discovery pace and dismissal mechanics. Read CMO 23.

During intake, attorneys may compare your records with common litigation patterns, including diagnosis type, exposure length, and supporting proof. They may also look at where to file and how your state's accrual and causation rules could apply. That does not guarantee a filing, but it helps answer whether a claim may meet basic pleading and proof requirements.

If a case proceeds, the process may include medical authorizations, employment and pesticide-use record collection, written discovery, and expert analysis. For many families, the legal timeline feels slow. Setting realistic expectations early helps: litigation often moves in phases, and major procedural rulings can change strategy for both sides.

What You Can Do Right Now

If you are facing a new Parkinson's diagnosis and a possible paraquat exposure history, a few concrete steps can reduce delay and confusion.

  1. Write a one-page timeline today with the years, locations, and product names you remember.
  2. Request complete medical records, including the first diagnosis notes and any differential-diagnosis discussion.
  3. Gather work and licensing records that show pesticide application or handling responsibilities.
  4. Do not use settlement headlines as a deadline guide.
  5. Start the intake checklist at Do I Qualify? and prepare for a state-specific case review.

What to Expect From the Legal Process

A paraquat claim usually starts with record review, not a courtroom hearing. Lawyers often evaluate diagnosis history, exposure timeline, and deadline risk before deciding whether a case should be filed. If a case is filed, the parties exchange evidence through discovery. That can include employment records, pesticide-use history, medical records, and witness testimony. In mass-tort litigation, this phase can take substantial time.

In MDL 3004, case-management orders show how quickly procedures can shift as motion practice and settlement talks evolve. That means an individual claimant may see timing changes driven by MDL-wide rulings, not just the facts of one case. The court has issued orders affecting trial-track planning, stays of case-specific deadlines, and dismissal mechanics after key motions. Read CMO 23.

Many readers also ask whether a case must go to trial to recover compensation. In practice, some mass-tort claims resolve through negotiated settlements, while others are dismissed or continue in litigation. Outcomes depend on legal rulings, proof strength, expert testimony, and case-specific facts. It is safer to think in terms of legal options, not guaranteed results.

If a case resolves, the timeline can still include lien review, final documentation, and court-related administrative steps before funds are distributed. If a case does not resolve, it may continue through additional motions or trial scheduling. Families planning around treatment and employment disruptions should leave room for that uncertainty.

A useful way to think about the process is to separate what you can control from what you cannot. You can control record gathering, timeline accuracy, and prompt legal consultation. You cannot control MDL-wide rulings or the pace of broader negotiations.

FAQ

Does paraquat cause Parkinson's disease?

Some studies report associations, and plaintiffs rely on those findings in litigation. EPA and California DPR, however, currently say the available evidence does not establish a clear direct causal link from labeled paraquat use. Read the EPA page.

Who qualifies for a paraquat lawsuit in 2026?

Potentially eligible claims often involve repeated paraquat exposure, a confirmed Parkinson's disease diagnosis, and a timely filing under applicable state law. Qualification still depends on the facts, available records, and the rules in the state where the claim is evaluated.

Is paraquat banned in the United States?

No. Paraquat remains federally registered as a restricted-use pesticide. It is limited to trained certified applicators, and EPA states there are no homeowner uses. Read the EPA page.

What is the status of the paraquat MDL in 2026?

The MDL is active, with thousands of pending actions as of April 1, 2026. Court orders show ongoing scheduling, motion practice, and settlement-related developments, so the litigation should be viewed as active but procedurally fluid. Read the JPML report.

How long do you have to file a paraquat lawsuit?

Many states commonly connected to paraquat claims use a two-year personal-injury baseline, but accrual and tolling rules can change the real deadline. Because a late filing can bar recovery, deadline analysis should be done with state-specific legal counsel.

Conclusion: How to Move Forward

A paraquat lawsuit in 2026 sits at the intersection of contested science, active federal litigation, and state-specific deadline rules. Some people may be in a strong position to pursue a claim, while others may face real evidentiary or timing barriers depending on diagnosis details and exposure history.

The most useful next step is to organize your records and get an individualized legal review. Start with Do I Qualify? to prepare your timeline and supporting details before speaking with counsel.

That early intake can help families avoid common mistakes, such as relying on memory alone for exposure years, overlooking older employment records, or treating media updates as legal deadline advice. Use this guide as a framework for better questions, then have qualified counsel apply those questions to your specific facts and jurisdiction.

General legal information only: this page is not legal advice and does not create an attorney-client relationship. Rights and deadlines depend on individual facts and state law. Consult a licensed attorney in your state for advice on your specific case.